Le Lézard
Classified in: Health, Science and technology, Business
Subject: PDT

Apoth?ka Systems Inc. Patents Patient Identity Validation On Blockchain


LOS ANGELES, Dec. 18, 2018 /PRNewswire/ -- On Tuesday December 18th Apoth?ka Systems Inc. announced the submittal of proprietary technology patents to the US Patent Office. This marks a milestone in the Healthcare EHR industry by making Apoth?ka a first if not the first company to use Blockchain technology to validate patient identity using a unique six way match validation algorithm as an integral part of patients Biometric points and Protected Health Information (PHI). 

Apotheka Systems Inc. (PRNewsfoto/Apotheka Systems Inc.)

"The company is now signing up early adopters and; the response has been overwhelming from hospitals to independent physicians due to high interest in the new disruptive Blockchain technology that has been long overdue!" Dennis Maliani (Founder)

The introduction of Blockchain technology has its origins in the crypto currency industry but its introduction to other industries has been gaining ground. "From the beginning we wanted to create something revolutionary in the Healthcare industry and we knew that the industry suffered from disparate patient data, privacy and security threats.

"In essence, we figured that if we could develop an eco-system that facilitated:

  1. Traceability workflow efficiencies,
  2. Data integrity centric,
  3. Enhanced security,
  4. Cost cutting;

we had the opportunity to create real change." Luis Lopez (COO) and Dennis Maliani (Founder)

Apoth?ka Systems Inc. has been working in the healthcare industry with various clients including Cedars Sinai Medical Center where they are customizing technology to fit the client's workflow needs. Apoth?ka is an innovator in the SaaS Blockchain EHR industry and provides an information exchange platform that connects hospitals to physicians to laboratories and insurance providers to facilitate quality patient care experience.

 

SOURCE Apotheka Systems Inc.


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: